SUBSEQUENT EVENTS (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
May 28, 2026 |
May 01, 2026 |
Mar. 31, 2025 |
Mar. 04, 2025 |
Jul. 14, 2026 |
Mar. 31, 2026 |
Dec. 31, 2024 |
Dec. 31, 2024 |
Mar. 31, 2026 |
Mar. 31, 2025 |
|
| Subsequent Event [Line Items] | ||||||||||
| Preferred stock, shares authorized | 9,979,400 | 9,979,400 | 9,979,400 | 9,979,400 | ||||||
| Preferred stock, shares issued | 1 | 1 | 1 | 1 | ||||||
| Preferred stock, shares outstanding | 1 | 1 | 1 | 1 | ||||||
| Common Stock [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Number of shares exchange | 1,706,820 | 789,604 | 2,506,020 | 4,365,022 | ||||||
| Number of conversion of shares | 2,173,089 | |||||||||
| Preferred Stock [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Number of shares exchange | ||||||||||
| Preferred stock, shares authorized | 10,000,000 | 10,000,000 | 10,000,000 | 10,000,000 | ||||||
| Subsequent Event [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Repayment in pricipal amount | $ 250,000 | |||||||||
| Accrued dividends | $ 64,055 | |||||||||
| Subsequent Event [Member] | Common Stock [Member] | Exchange Shares Agreement [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Number of shares issued | 14,144,325 | |||||||||
| Subsequent Event [Member] | Common Stock [Member] | Exchange Options Agreement [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Number of shares issued | 3,992,427 | |||||||||
| Subsequent Event [Member] | Common Stock [Member] | Exchange Warrants Agreement [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Number of shares issued | 1,436,216 | |||||||||
| Series B Preferred Stock [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Number of shares issued | 1,431,181 | 2,867,448 | 550 | |||||||
| Number of conversion of shares | 25 | 25 | 75 | 30 | ||||||
| Preferred stock, shares authorized | 600 | 600 | 600 | 600 | ||||||
| Preferred stock, shares issued | 385 | 335 | 335 | 385 | ||||||
| Preferred stock, shares outstanding | 385 | 335 | 335 | 385 | ||||||
| Series B Preferred Stock [Member] | Subsequent Event [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Number of shares issued | 805,609 | |||||||||
| Series C Preferred Stock [Member] | Subsequent Event [Member] | Preferred Stock [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Reverse stock split | the Board of Directors of Biotricity and 6 stockholders holding an aggregate of 1,298,945 shares of Series C Preferred stock issued and outstanding as of May 28, 2026 representing 51,957,780 votes have approved and consented to an amendment to the articles of incorporation to effect a future reverse stock split. | |||||||||
| Preferred stock, shares issued | 1,298,945 | |||||||||
| Preferred stock, shares outstanding | 1,298,945 | |||||||||
| Series C Preferred Stock [Member] | Subsequent Event [Member] | Preferred Stock [Member] | Exchange Agreements [Member] | ||||||||||
| Subsequent Event [Line Items] | ||||||||||
| Number of shares exchange | 1,957,297 | |||||||||
| Preferred stock, shares authorized | 2,100,000 | |||||||||
| Preferred stock, voting rights | Holders of Series C Preferred Stock (the “Series C Holders”) will be entitled to 40 votes for each share of Series C Preferred Stock. Effective upon the closing of any offering of equity securities in which the Company receives gross proceeds of at least $15 million (a “Qualified Financing”), outstanding shares of Series C Preferred Stock will automatically convert into an aggregate of 59.6% of the Company’s outstanding shares of common stock (the “Conversion Shares”). In the event the Company issues warrants in such Qualified Financing, Series C Holders will also receive warrants in the form issued in the Qualified Financing and in the same ratio to the Conversion Shares as the warrant coverage in the Qualified Financing. | |||||||||
| Preferred stock, conversion basis | In the event the Company has not consummated a Qualified Financing by March 31, 2028, Series C Holders will have the right to convert each share of Series C Preferred Stock to 10 shares of common stock. In connection with the foregoing, the Company relied upon the exemption from registration under Section 4(a)(2) under the Securities Act of 1933, as amended, for transactions not involving a public offering. | |||||||||